A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women.
The purpose of this study was to prospectively examine the relation of dehydroepiandrosterone sulfate (DHEAS) to bone mineral density in a community-based sample of 260 men and 162 women who were residents of Rancho Bernardo, California. DHEAS levels had been measured in plasma obtained in 1972-1974 when the men were 50-74 years of age and the women were 55-74. In 1988-1991, bone mineral density was measured at the lumbar spine and hip using dual x-ray absorptiometry, and at the mid-radius and ultradistal radius using single photon absorptiometry. Among men, there was a significant decrease in DHEAS levels and bone mineral density at the hip, ultradistal radius, and midshaft radius with increasing age. However, for both men and women, there was no significant association of DHEAS levels with bone mineral density at any site, both before and after adjustment for age, obesity, cigarette smoking, and use of antihypertensive medications. These data do not support the hypothesis of DHEAS having a causal role in senile osteoporosis.
Barrett-Connor
E
E
Department of Community and Family Medicine, University of California, San Diego, La Jolla.
Kritz-Silverstein
D
D
Edelstein
S L
SL
D015502:Absorptiometry, Photon; D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects; D015519:Bone Density / Q000187:drug effects*; D002140:California / Q000453:epidemiology; D003687:Dehydroepiandrosterone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood; D019314:Dehydroepiandrosterone Sulfate; D005215:Fasting; D005260:Female; D006801:Humans; D016014:Linear Models; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D010024:Osteoporosis / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000453:epidemiology*; D011446:Prospective Studies; D011877:Radionuclide Imaging; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
D000959:Antihypertensive Agents; D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate